• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday

    8/1/22 5:27:59 AM ET
    $AHG
    $AKTX
    $AMTD
    $AMTX
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AHG alert in real time by email

    Gainers

    • Getty Images Holdings, Inc. (NYSE:GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).
    • Brookline Capital Acquisition Corp. (NASDAQ:BCAC) gained 127.3% to settle at $22.71.
    • AMTD Digital Inc. (NYSE:HKD) surged 122.4% to settle at $400.25 on continued post-IPO volatility.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) climbed 68.3% to close at $3.13 after declining 5% on Thursday.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) gained 51.6% to close at $0.7930. The U.S. Food and Drug Administration (FDA) recently declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) gained 40.2% to close at $4.74.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) gained 38.1% to settle at $24.82 on continued volatility after the company completed its SPAC merger agreement last month.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) surged 37.2% to settle at $2.73. GeoVax Labs announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus.
    • MAIA Biotechnology, Inc. (NYSE:MAIA) gained 30% to close at $5.80. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) jumped 28.7% to settle at $2.47.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) gained 27% to close at $0.2694 after gaining over 6% on Thursday.
    • Regional Health Properties, Inc. (NYSE:RHE) surged 26.8% to settle at $4.69.
    • AXT, Inc. (NASDAQ:AXTI) shares climbed 24.9% to close at $8.77 after the company reported better-than-expected Q2 EPS.
    • Nano Labs Ltd (NASDAQ:NA) gained 23.3% to settle at $9.62 amid post-IPO volatility after the stock opened for trade earlier in the month.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) gained 23.3% to close at $1.48. Mobiquity Technologies looks to launch a multi-national ad campaign using the Mobiquity CryptoGraph technology to drive awareness for the BlockBusters token on August 2.
    • Sonder Holdings Inc. (NASDAQ:SOND) rose 23% to close at $1.55.
    • TuanChe Limited (NASDAQ:TC) jumped 23% to settle at $1.82.
    • AMTD IDEA Group (NYSE:AMTD) gained 22.2% to settle at $1.76.
    • FaZe Holdings Inc. (NASDAQ:FAZE) jumped 22% to close at $13.09 amid continued post-IPO volatility.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) climbed 21.8% to close at $2.91 after the company reported better-than-expected Q2 sales results and EPS results were higher year over year.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 21% to close at $7.09. The company entered into an agreement with Ace Hardware USA to sell 35 products across 5,500 stores.
    • Akari Therapeutics, Plc (NASDAQ:AKTX) gained 20.6% to settle at $1.14.
    • Akari Therapeutics reported results from recent pre-clinical studies of Investigational PASylated Nomacopan that support the potential to advance research toward IND/IMPD for clinical trials in geographic atrophy.
    • Mitek Systems, Inc. (NASDAQ:MITK) rose 20.6% to close at $10.88 after the company reported better-than-expected Q3 results.
    • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) rose 19.6% to close at $1.71. Ayala Pharmaceuticals recently filed a request for the withdrawal of the Registration Statement on Form S-1.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) gained 19.4% to close at $17.25. Shares of solar companies traded higher in sympathy with First Solar, which reported strong Q2 results and raised guidance.
    • World Fuel Services Corporation (NYSE:INT) climbed 19.1% to close at $27.72 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Nouveau Monde Graphite Inc. (NYSE:NMG) rose 18.4% to close at $4.77.
    • Sunworks, Inc. (NASDAQ:SUNW) gained 18.4% to close at $2.38. Shares of solar companies traded higher in sympathy with First Solar, which reported strong Q2 results and raised guidance
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) rose 17.8% to settle at $3.17 as stocks related to clean energy continue to gain amid optimism towards US climate change efforts.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) gained 17.6% to settle at $16.21.
    • InflaRx N.V. (NASDAQ:IFRX) gained 17.6% to settle at $2.74. InflaRX recently announced plans to apply for Emergency Use Authorization from the FDA for vilobelimab for the treatment of critically ill COVID-19 patients.
    • CVRx, Inc. (NASDAQ:CVRX) climbed 17% to close at $8.83 after the company reported better-than-expected Q2 sales results.
    • Core Scientific, Inc. (NASDAQ:CORZ) gained 16.7% to close at $2.51.
    • Clearfield, Inc. (NASDAQ:CLFD) gained 16.5% to settle at $98.55 after the company reported better-than-expected Q3 EPS and sales results.
    • OKYO Pharma Limited (NASDAQ:OKYO) jumped 15.8% to close at $2.3501.
    • Data I/O Corporation (NASDAQ:DAIO) gained 15.3% to close at $3.54 following strong Q2 results.
    • Carrols Restaurant Group, Inc. (NASDAQ:TAST) gained 15.3% to settle at $2.49.
    • Aemetis, Inc. (NASDAQ:AMTX) climbed 15% to settle at $7.35.
    • Sequans Communications S.A. (NYSE:SQNS) gained 14.1% to close at $3.00.
    • SAI.TECH Global Corporation (NASDAQ:SAI) gained 13.9% to close at $6.14.
    • U.S. Silica Holdings, Inc. (NYSE:SLCA) gained 13% to close at $13.83 after the company reported better-than-expected Q2 EPS and sales results.
    • Q&K International Group Limited (NASDAQ:QK) rose 12.3% to close at $2.10.
    • Transocean Ltd. (NYSE:RIG) rose 12.3% to close at $3.38.
    • Haynes International, Inc. (NASDAQ:HAYN) rose 12.2% to settle at $38.66 after the company reported better-than-expected Q3 results.
    • Omeros Corporation (NASDAQ:OMER) climbed 11.4% to close at $4.98 after the FDA granted Orphan Drug Designation to OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria.
    • DAVIDsTEA Inc. (NASDAQ:DTEA) gained 10.4% to close at $1.49.
    • Amazon.com, Inc. (NASDAQ:AMZN) jumped 10.4% to close at $134.95 after the company reported better-than-expected results for its second quarter. The company said it expects-third quarter net sales to be in a range of $125 billion to $130 billion, up 13% to 17% year-over-year.
    • Five9, Inc. (NASDAQ:FIVN) gained 9.9% to close at $108.12 after the company reported better-than-expected Q2 results and issued strong guidance.
    • CHW Acquisition Corporation (NASDAQ:CHWA) gained 9.2% to close at $10.10. CHW Acquisition’s stockholders approved proposed merger transaction with Wag Labs, Inc.
    • Deckers Outdoor Corporation (NYSE:DECK) gained 9% to close at $313.21 after the company reported better-than-expected Q1 EPS and sales results.
    • Chevron Corporation (NYSE:CVX) rose 8.9% to settle at $163.78 after the company reported better-than-expected Q2 EPS and sales results.
    • Chart Industries, Inc. (NYSE:GTLS) gained 8.9% to close at $195.09 following Q2 earnings.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) gained 8.5% to close at $2.56.
    • Graham Corporation (NYSE:GHM) gained 8.3% to close at $7.15 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Rite Aid Corporation (NYSE:RAD) rose 7.9% to close at $8.23. Traders circulated Dealreporter chatter that activists might be eyeing the company.
    • Houston American Energy Corp. (NYSE:HUSA) gained 7% to close at $4.41.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 6.6% to close at $2.90.
    • Resources Connection, Inc. (NASDAQ:RGP) rose 6% to close at $21.46 following upbeat Q4 earnings.
    • Apple Inc. (NASDAQ:APPL) rose 3.3% to close at $162.51 as the company reported better-than-expected results for its fiscal year third-quarter, helped by strong iPhone and iPad sales.


    Losers

    • Virax Biolabs Group Limited (NASDAQ:VRAX) tumbled 74% to settle at $5.40 on Friday as the stock pulled back after surging recently following the company's announcement of a distribution of Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kits.
    • Lottery.com Inc. (NASDAQ:LTRY) shares dipped 63.8% to close at $0.2950 on Friday after the company in an SEC filing said its board determined it does not have sufficient financial resources to fund operations.
    • Avaya Holdings Corp. (NASDAQ:AVYA) shares tumbled 57% to settle at $0.8986 after the company cut Q3 revenue guidance. Craig-Hallum downgraded Avaya from Buy to Hold.
    • Holley Inc. (NYSE:HLLY) fell 36.9% to close at $7.99 after the company lowered its FY22 sales guidance below analyst estimates.
    • Nutriband Inc. (NASDAQ:NTRB) fell 34.1% to close at $5.12.
    • TOP Financial Group Limited (NASDAQ:TOP) dropped 29.9% to close at $9.99.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) dropped 24.6% to close at $0.6359.
    • Athersys, Inc. (NASDAQ:ATHX) dipped 23.4% to close at $0.2491.
    • Roku, Inc. (NASDAQ:ROKU) shares fell 23.1% to settle at $65.52 after the company reported weaker-than-expected financial results for its second quarter and withdrew its full-year revenue growth guidance. Roku said it expects third-quarter revenue to increase about 3% year-over-year to $700 million.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) declined 23.1% to close at $17.19 after the FDA announced there is currently no human data demonstrating the efficacy of Tpoxx for the treatment of Monkeypox.
    • Femasys Inc. (NASDAQ:FEMY) dipped 20.6% to close at $1.70.
    • VivoPower International PLC (NASDAQ:VVPR) declined 18.1% to settle at $1.13. VivoPower International reported pricing of $5.5 million offering.
    • Cryptyde, Inc. (NASDAQ:TYDE) dropped 17.8% to close at $1.11.
    • BiomX Inc. (NYSE:PHGE) fell 16.2% to settle at $0.8972.
    • Missfresh Limited (NASDAQ:MF) shares dropped 14.9% to close at $0.1151 after the company adopted significant business strategy adjustments. The company received RMB200 million equity investment pursuant to investment agreement and highlighted temporary shutdown of on-demand distributed mini warehouse.
    • ObsEva SA (NASDAQ:OBSV) fell 14.9% to close at $0.2570 as the company reported the resignation of Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research & Development, effective September 30, 2022.
    • SKYX Platforms Corp. (NASDAQ:SKYX) fell 14.8% to close at $5.99. Benchmark, on Thursday, initiated coverage on the stock with a Buy rating and announced a $15 price target.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) declined 14.5% to close at $4.36.
    • Akso Health Group (NASDAQ:AHG) dropped 14.4% to settle at $0.89.
    • Green Giant Inc. (NASDAQ:GGE) fell 14% to close at $2.28.
    • Bridgford Foods Corporation (NASDAQ:BRID) declined 14% to close at $12.64.
    •  
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 13.5% to close at $1.67.
    • Great Panther Mining Limited (NYSE:GPL) fell 13.5% to settle at $0.96.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 12.9% to close at $2.64.
    • Nuvalent, Inc. (NASDAQ:NUVL) dropped 12.6% to settle at $14.86.
    • VolitionRx Limited (NYSE:VNRX) fell 11% to close at $2.03 after the company reported pricing of $6 million underwritten public offering of common stock.
    • Avantor, Inc. (NYSE:AVTR) shares fell 10.2% to close at $29.02 after the company reported worse-than-expected Q2 EPS and sales results.
    • Bausch Health Companies Inc. (NYSE:BHC) dipped 9.4% to close at $4.62 after several analysts downgraded the stock amid concerns. The stock has fallen over the past two sessions amid an expected court decision in the XIFAXAN patent litigation.
    • QualTek Services Inc. (NASDAQ:QTEK) fell 9% to close at $1.21.
    • Intel Corporation (NASDAQ:INTC) fell 8.6% to close at $36.31 after the company reported worse-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 EPS and sales guidance below analyst estimates.
    • DexCom, Inc. (NASDAQ:DXCM) fell 5.6% to close at $82.08 after the company reported worse-than-expected Q2 EPS and sales results.
    Get the next $AHG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHG
    $AKTX
    $AMTD
    $AMTX

    CompanyDatePrice TargetRatingAnalyst
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Amazon.com Inc.
    $AMZN
    2/23/2026$305.00 → $304.00Overweight
    Wells Fargo
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    Deckers Outdoor Corporation
    $DECK
    2/20/2026Hold → Buy
    Argus
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Transocean Ltd (Switzerland)
    $RIG
    2/18/2026$6.00Overweight → Equal Weight
    Barclays
    Chevron Corporation
    $CVX
    2/17/2026$205.00Hold → Buy
    Melius
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    More analyst ratings

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lucier Gregory T bought $458,000 worth of shares (50,000 units at $9.16) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/23/26 8:53:53 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Jain Mudit K. bought $297,592 worth of shares (46,800 units at $6.36) (SEC Form 4)

    4 - CVRx, Inc. (0001235912) (Issuer)

    2/23/26 6:00:12 AM ET
    $CVRX
    Medical/Dental Instruments
    Health Care

    Director Jain Mudit K. bought $2,785 worth of shares (600 units at $4.64), increasing direct ownership by 12% to 5,650 units (SEC Form 4)

    4 - CVRx, Inc. (0001235912) (Issuer)

    2/18/26 5:22:25 PM ET
    $CVRX
    Medical/Dental Instruments
    Health Care

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Wells Fargo reiterated coverage on Amazon with a new price target

    Wells Fargo reiterated coverage of Amazon with a rating of Overweight and set a new price target of $304.00 from $305.00 previously

    2/23/26 10:45:11 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Piper Sandler initiated coverage on OKYO Pharma with a new price target

    Piper Sandler initiated coverage of OKYO Pharma with a rating of Overweight and set a new price target of $7.00

    2/20/26 8:25:04 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHG
    $AKTX
    $AMTD
    $AMTX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OpenAI and Amazon Announce Strategic Partnership

    Amazon Web Services (AWS) and OpenAI will co-create a Stateful Runtime Environment powered by OpenAI models, available on Amazon Bedrock for AWS customers to build generative AI applications and agents at production scale AWS will be the exclusive third-party cloud distribution provider for OpenAI Frontier, which enables organizations to build, deploy, and manage teams of AI agents OpenAI to consume 2 gigawatts of Trainium capacity through AWS infrastructure to support demand for Stateful Runtime Environment, Frontier, and other advanced workloads OpenAI and Amazon will develop customized models available to power Amazon's customer-facing applications Amazon will invest $50 billion

    2/27/26 8:30:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Dexcom Appoints Rick Osterloh to Board of Directors

    DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a highly accomplished technology executive with more than 20 years of leadership experience across consumer hardware, platform strategy and large-scale product operations. He currently serves as Senior Vice President, Platforms & Devices at Google, where he leads a unified group spanning the company's portfolio of advanced consumer technologies. This includes Android, Google Play, Chrome, and Google's Devices and Services Portfolio—Pixel phones, Google Nest smart home devices, and Fitbit wearables. Und

    2/26/26 4:15:00 PM ET
    $DXCM
    Medical/Dental Instruments
    Health Care

    Data I/O Reports Fourth Quarter 2025 Results

    A Year of Strategic Progress for New Programming Innovations and Expanding Addressable Market AI-enabled Transformation Leading to Programming Acceleration and Operational Efficiencies/Expense Reductions;2026 Business Framework Initiated – Data I/O Returns to Growth REDMOND, Wash., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Data I/O Corporation (NASDAQ:DAIO), the leading global provider of data programming and security provisioning solutions for microcontrollers, security ICs and memory devices, today announced financial results for the fourth quarter ended December 31, 2025. 2025 and Recent Highlights Strategic transformation approximately one year ahead of scheduleInvestments in core product

    2/26/26 4:00:00 PM ET
    $DAIO
    Electrical Products
    Industrials

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Leadership Updates

    Live Leadership Updates

    View All

    Dexcom Appoints Rick Osterloh to Board of Directors

    DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a highly accomplished technology executive with more than 20 years of leadership experience across consumer hardware, platform strategy and large-scale product operations. He currently serves as Senior Vice President, Platforms & Devices at Google, where he leads a unified group spanning the company's portfolio of advanced consumer technologies. This includes Android, Google Play, Chrome, and Google's Devices and Services Portfolio—Pixel phones, Google Nest smart home devices, and Fitbit wearables. Und

    2/26/26 4:15:00 PM ET
    $DXCM
    Medical/Dental Instruments
    Health Care

    Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Prafulla Gokhale, Ph.D., Director of the Experimental Therapeutics Core and the Lurie Family Imaging Center at Dana-Farber Cancer Institute, to its Scientific Advisory Board. "Dr. Gokhale's expertise in experimental therapeutics, RNA biology and translational oncology comes at a pivotal time as we advance AKTX-101 toward the clinic," commented Abizer Gaslightwala, President and CEO of Akari Therapeutics. "His proven track record to develop novel t

    2/26/26 9:10:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Olga Anczukow, Ph.D. to its Scientific Advisory Board (SAB). Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics commented, "Dr. Anczukow is a leading authority in RNA splicing and cancer biology, an area of growing importance for the development of next-generation therapeutics. Her scientific rigor, translational mindset, and experience advancing RNA-focused discoveries toward clinical relevance make her an outstandin

    2/23/26 8:50:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burkland Michael exercised 54,375 shares at a strike of $8.13, increasing direct ownership by 16% to 403,945 units (SEC Form 4)

    4 - Five9, Inc. (0001288847) (Issuer)

    2/26/26 5:41:29 PM ET
    $FIVN
    EDP Services
    Technology

    Chief Admin. & Legal Officer Meriweather Tiffany N. was granted 104,931 shares, increasing direct ownership by 49% to 317,057 units (SEC Form 4)

    4 - Five9, Inc. (0001288847) (Issuer)

    2/26/26 5:15:38 PM ET
    $FIVN
    EDP Services
    Technology

    VP, GC and Secretary Hotchkiss Herbert was granted 1,242 shares and covered exercise/tax liability with 374 shares, increasing direct ownership by 4% to 23,696 units (SEC Form 4)

    4 - CHART INDUSTRIES INC (0000892553) (Issuer)

    2/26/26 4:51:52 PM ET
    $GTLS
    Metal Fabrications
    Industrials

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Financials

    Live finance-specific insights

    View All

    Data I/O Reports Fourth Quarter 2025 Results

    A Year of Strategic Progress for New Programming Innovations and Expanding Addressable Market AI-enabled Transformation Leading to Programming Acceleration and Operational Efficiencies/Expense Reductions;2026 Business Framework Initiated – Data I/O Returns to Growth REDMOND, Wash., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Data I/O Corporation (NASDAQ:DAIO), the leading global provider of data programming and security provisioning solutions for microcontrollers, security ICs and memory devices, today announced financial results for the fourth quarter ended December 31, 2025. 2025 and Recent Highlights Strategic transformation approximately one year ahead of scheduleInvestments in core product

    2/26/26 4:00:00 PM ET
    $DAIO
    Electrical Products
    Industrials

    Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call

    HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025, on Thursday, March 5, 2026, after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, March 6, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and

    2/25/26 5:29:00 PM ET
    $NUTX
    Real Estate

    Getty Images to Release Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. ("Getty Images") (NYSE:GETY) a preeminent global visual content creator and marketplace, announced today that the company intends to release its fourth quarter and full year 2025 results after market close on Monday, March 16, 2026, followed by a conference call at 4:30 p.m. (Eastern Time) that same day to discuss the company's results. The conference call can be accessed live over the phone by dialing 1-800-245-3047, or for international callers, 1-203-518-9765. The conference ID for the call is GETTYQ4. An audio replay will be available for two weeks following the call and can be accessed by dialing 1-844-512-2921,

    2/25/26 4:07:00 PM ET
    $GETY
    Real Estate

    $AHG
    $AKTX
    $AMTD
    $AMTX
    SEC Filings

    View All

    SEC Form 20-F filed by AMTD Digital Inc.

    20-F - AMTD Digital Inc. (0001809691) (Filer)

    2/27/26 4:03:50 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    Clearfield Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Clearfield, Inc. (0000796505) (Filer)

    2/27/26 12:45:25 PM ET
    $CLFD
    Telecommunications Equipment
    Utilities

    Amazon.com Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - AMAZON COM INC (0001018724) (Filer)

    2/27/26 8:36:30 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AHG
    $AKTX
    $AMTD
    $AMTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care